Fitbit tapped physicians from Boston-based Massachusetts General Brigham and Portland-based Oregon Health & Science University to consult on the project before starting production. The company is preparing to submit plans to the FDA under its Emergency Use Authorization in the coming days.
Under EUA certification, the device would be allowed for use specifically for COVID-19 patients. The ventilators are intended as temporary or short-term and will feature capabilities somewhere between an emergency ventilator and a premium grade device, according to the report.
More articles on digital transformation:
‘We either have to succeed fast or fail fast’: How Houston Methodist’s innovation hub is making its mark
HHS to award $5M for digital healthcare innovation
Boston Children’s to use patient-provider matching software from Kyruus
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
